Clinical trial
Evaluating Collagen Cross-Linking (CCL) Treatment in Norway
NCT00435799 · Ullevaal University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00435799 |
|---|---|
| Title | Evaluating Collagen Cross-Linking (CCL) Treatment in Norway |
| Official title | Treatment of Keratectasia With Collagen Cross-Linking (CCL) at the Eye Departments of the University Hospital, North Norway in Tromsø and Ullevål University Hospital in Oslo |
| Lead sponsor | Ullevaal University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Keratoconus |
| Intervention type | Device, Drug, Procedure |
| Interventions | corneal cross-linking (CCL), Riboflavin/dextran eyedrops, UV-X system |
| Enrollment | 40 |
| Start date | Feb 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2010 |
| First posted | Feb 15, 2007 |
| Last update posted | Jun 10, 2008 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: